"Designing Growth Strategies is in our DNA"

U.S. Point-of-Care Sepsis Diagnostics Market Size, Share & Industry Analysis, By Product Type (Instruments and Reagents & Kits), By Technology (Molecular Diagnostics and Immunoassays), By Pathogen (Bacterial Sepsis and Fungal Sepsis), By End User (Hospitals & Clinics and Standalone Laboratories), and Country Forecast, 2024-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI110815

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Sepsis Incidence in U.S., 2023
    2. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
    3. Overview: Point of Care Sepsis Diagnostics, By Emerging Companies
    4. Technological Advancements in Point-of-Care Sepsis Diagnostics
    5. Regulatory & Reimbursement Scenario
    6. Impact of COVID-19 Pandemic on Point-of-Care Sepsis Diagnostics Market
  5. U.S. Point-of-Care Sepsis Diagnostics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Kits
    2. Market Analysis, Insights and Forecast – By Technology
      1. Molecular Diagnostics
      2. Immunoassays
    3. Market Analysis, Insights and Forecast – By Pathogen
      1. Bacterial Sepsis
      2. Fungal Sepsis
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Standalone Laboratories
  6. Competitive Analysis
    1. Market Share Analysis (2023)
    2. Key Companies for Countries in the Scope
    3. Company Profiles
      1. Abbott
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Thermo Fisher Scientific Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      3. Radiometer Medical ApS (Danaher)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      4. bioMérieux, Inc. (France)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      5. DiaSorin S.p.A. (Italy)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      6. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      7. Siemens Healthineers AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      8. T2 Biosystems, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Sepsis Incidence in U.S., 2023
    2. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
    3. Overview: Point of Care Sepsis Diagnostics, By Emerging Companies
    4. Technological Advancements in Point-of-Care Sepsis Diagnostics
    5. Regulatory & Reimbursement Scenario
    6. Impact of COVID-19 Pandemic on Point-of-Care Sepsis Diagnostics Market
  5. U.S. Point-of-Care Sepsis Diagnostics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Kits
    2. Market Analysis, Insights and Forecast – By Technology
      1. Molecular Diagnostics
      2. Immunoassays
    3. Market Analysis, Insights and Forecast – By Pathogen
      1. Bacterial Sepsis
      2. Fungal Sepsis
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Standalone Laboratories
  6. Competitive Analysis
    1. Market Share Analysis (2023)
    2. Key Companies for Countries in the Scope
    3. Company Profiles
      1. Abbott
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Thermo Fisher Scientific Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      3. Radiometer Medical ApS (Danaher)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      4. bioMérieux, Inc. (France)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      5. DiaSorin S.p.A. (Italy)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      6. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      7. Siemens Healthineers AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      8. T2 Biosystems, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: U.S. Point-of-Care Sepsis Diagnostics Market Revenue Breakdown (USD million, %) by Product Type, 2023 & 2032

Figure 2: U.S. Point-of-Care Sepsis Diagnostics Market Value Share (%), by Product Type, 2023 & 2032

Figure 3: U.S. Point-of-Care Sepsis Diagnostics Market Value Share (%), by Technology, 2023 & 2032

Figure 4: U.S. Point-of-Care Sepsis Diagnostics Market Value Share (%), by Pathogen, 2023 & 2032

Figure 5: U.S. Point-of-Care Sepsis Diagnostics Market Value Share (%), by End User, 2023 & 2032

Figure 6: U.S. Point-of-Care Sepsis Diagnostics Market Share (%), 2023

Table 1: U.S. Point-of-Care Sepsis Diagnostics Market Revenue (USD million) Forecast, by Product Type, 2019–2032

Table 2: U.S. Point-of-Care Sepsis Diagnostics Market Revenue (USD million) Forecast, by Technology, 2019–2032

Table 3: U.S. Point-of-Care Sepsis Diagnostics Market Revenue (USD million) Forecast, by Pathogen, 2019–2032

Table 4: U.S. Point-of-Care Sepsis Diagnostics Market Revenue (USD million) Forecast, by End User, 2019-2032

US Point of Care Sepsis Diagnostics Market
  • 2019-2032
  • 2023
  • 2019-2022
  • 143
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports